MARKET

XNCR

XNCR

Xencor
NASDAQ
12.30
+0.30
+2.50%
Opening 11:36 03/16 EDT
OPEN
11.75
PREV CLOSE
12.00
HIGH
12.41
LOW
11.75
VOLUME
177.16K
TURNOVER
--
52 WEEK HIGH
18.69
52 WEEK LOW
6.92
MARKET CAP
902.07M
P/E (TTM)
-9.9338
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XNCR last week (0309-0313)?
Weekly Report · 6h ago
Xencor’s Lung Cancer Trial Halted: What the Vudalimab Update Means for XNCR Investors
TipRanks · 2d ago
Xencor Insider Shake-Up: Top Executives Quietly Cash Out Shares
TipRanks · 6d ago
Xencor, Genentech to End Protein Therapeutics Collaboration
TipRanks · 6d ago
Genentech Terminates Collaboration Agreement With Xencor
Dow Jones · 6d ago
Xencor reports receipt of notice of termination of license agreement from Roche
TipRanks · 6d ago
Weekly Report: what happened at XNCR last week (0302-0306)?
Weekly Report · 03/09 09:05
Controversial Prasad leaving FDA, NYT reports
TipRanks · 03/08 20:55
More
About XNCR
Xencor, Inc. is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases. It has more than 20 candidates engineered with its XmAb technology that are in clinical development, and multiple XmAb medicines are marketed by partners. Its XmAb engineering technology enables small changes to a protein structure that result in new mechanisms of therapeutic action. Its wholly-owned development candidates include XmAb942, XmAb819, XmAb808, and XmAb541. Candidates co-developed with partners include Plamotamab. Its clinical-stage drug candidates advanced by partners include Xaluritamig (AMG 509), ASP2138, JNJ-9401, JNJ-1493, Xpro1595, Obexelimab, and Novartis XmAb, an undisclosed antibody candidate. Its cytokine drug candidates in clinical development consist of efbalropendekin alfa (XmAb306/RG6323). Its Vudalimab is a bispecific antibody that targets PD-1 and CTLA-4.

Webull offers Xencor Inc stock information, including NASDAQ: XNCR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XNCR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XNCR stock methods without spending real money on the virtual paper trading platform.